Prix XtalPi Holdings Limited (02228.HK)

XtalPi Holdings Ltd. provides drug and material science R&D solutions and services to global conglomerates and companies in the pharmaceutical and material science industries. The company is headquartered in Shenzhen, Guangdong and currently employs 1,054 full-time employees. The company went IPO on 2024-06-13. The firm mainly operates two businesses. The drug discovery solutions business is engaged in providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The intelligent automation solutions business is engaged in the provision of solid-state research and development services and automated chemical synthesis services. The firm conducts its business in the domestic and overseas markets.